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Abstract
Introduction: Necrobiosis lipoidica diabeticorum is a rare disease of unclear etiology, that occurs
in about 1% of diabetic patients.
Case report: We present case of granulomatosis disciformis chronica et progressiva Miescher
with good response to systemic corticosteroids therapy.
Patient 45 years old woman, with primary yellow-brown areas skin lesions, with foci well separated
from surroundings on both lower legs, that occurred 5 years ago. In laboratory tests there was no
abnormalities. Because of advance suggestion (after last admit in dermatological ward) of
observation according to xantogranuloma necrobioticum tests for paraproteinemia were made.
Immunoelectrophoresis, IgG, IgM, IgA levels, kappa light chain, lambda heavy chain; were correct,
Bence-Johns protein-negative. During hospitalization in Clinic methylprednisolone in dose of 32 mg
od, vascular drugs and local steroidotherapy was applied with good therapeutic response.
Conclusion:  We described case of typical clinical and histological characters of necrobiosis
lipoidica. without diabetes-granulomatosis disciformis chronica et progressiva Miescher that
despite of suspicion of proper diagnosis for a long time was not treat effective.
Introduction
Necrobiosis lipoidica diabeticorum is a rare disease of
unclear etiology that occurs in about 1% of diabetic
patients [1]. The disease is characterized by a chronic
inflammatory granulomatous process accompanied by
vasculitis with perivascular deposits of complement C3
and immunoglobulins IgG, IgM and IgA. Typically found
on the lower legs, focal skin lesions comprise well-sepa-
rated irregular areas of discolored (yellow-brown) tissue.
Tissue damage in the centre of foci includes atrophy, scle-
rosis and teleangiectasia [1-3].
Miescher's granulomatosis (also known as granulomato-
sis disciformis chronica et progressiva) was first reported
by Miescher and Leder in 1948. In this condition skin
lesions are typically localized bilaterally and symmetri-
cally on the lower legs, and in the absence of diabetes
[1,4]. Treatment of all types of necrobiosis lipoidica is dif-
ficult, and the condition can be unresponsive to systemic
corticosteroids, cyclosporin A, retinoids, and antimalarial
and vascular drugs. In contrast, some promising results
have been obtained with phototherapy (psoralen and
UVA treatment; PUVA), with topical application of corti-
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costeroids or tacrolimus, or with photodynamic therapy
[5-11].
We present a case of Miescher's granulomatosis without
diabetes showing a favorable response to systemic corti-
costeroid therapy.
Case report
The patient (female, 45 yr) had primary skin lesions con-
sisting of discolored (yellow-brown) areas on both lower
legs with well-separated foci (Fig. 1). Her condition was
first reported 5 years earlier. The initial diagnosis was ery-
thema induratum, and treatment included penicillin G
procaine, rifampicin, vascular drugs and local steroido-
therapy. Diagnosis of Miescher's granulomatosis was sug-
gested 3 years later on the basis of histopathologic
examination and after exclusion of diabetes. We repeated
penicillin G procaine, vascular drug administration and
steroidotherapy. Cryotherapy with ethyl chloride was also
applied. Despite the treatment the extent of the skin
lesions increased slowly and these were accompanied by
with small ulcerations within the lesion foci, often as a
result of local injury.
Thyroid disease was diagnosed in 2007 (Hashimoto's thy-
roiditis; struma nodosa partim lymphomatosa Hashim-
oto) and subtotal resection of the thyroid gland was
performed. Thyroid hormone replacement was with
Eltroxin (levothyroxine, 100 mg). In the same year the
patient was hospitalized in a provincial dermatological
ward where a diagnosis of xanthogranuloma necrobioti-
cum was suggested. Because treatment brought no
improvement, and the extent of the skin lesions contin-
ued to increase, the patient was admitted to Department
of Dermatology at Katowice Medical University.
Laboratory investigations included ESR 32/52, blood
smear, electrolyte levels, AspAT, ALAT, GGTP, bilirubin,
creatinine, urea, glucose, blood glucose profile, blood
protein electrophoresis, CPK, aldolase, urine analysis,
arthus-type reactions (latex-R, Waaler-Rose test, ASO). All
were in the normal range. Because xanthogranuloma
necrobioticum had been suggested tests for paraproteine-
mia were also performed. Immunoelectrophoresis
revealed normal levels of IgG, IgM, IgA, kappa light chain,
and lambda heavy chain; there was no evidence of Bence-
Jones proteins.
In therapy methylprednisolone (32 mg od) was adminis-
tered in conjunction with vascular drugs and local steroi-
dotherapy. After 1 month of methylprednisolone there
was significant improvement, with flattening and blanch-
ing of skin lesions accompanied by healing of minor
ulcerations on the left lower leg. The patient is now receiv-
ing dermatologic out-patient care with continued admin-
istration of methylprednisolone and gradual dose
reduction (table 1).
Discussion
Necrobiosis lipoidica in its classical form is a granuloma-
tous disease of unclear etiology usually associated with
diabetes. Ho et al. [12] reported on an atypical familial
case where necrobiosis lipoidica without diabetes was
found in 2 sisters. Flann et al. [13] and Criado et al. [14]
described many histological similarities between the pro-
gression of xanthogranuloma necrobioticum and Mie-
scher's granulomatosis, although the overall clinical
picture differs between the two conditions. Leroy et al.
[15] performed electron microscope ultrastructural stud-
ies in a patient (62 yr) with a diagnosis of necrobiosis
lipoidica without diabetes. Here perivascular macrophage
infiltration, necrobiosis and collagen fiber damage was
reported but without loss of vascular wall integrity.
Treatment of classical variants of necrobiosis lipoidica
and Miescher's granulomatosis is difficult. Bawaria et al.
[16] applied pentoxifylline (3 × 400 mg td) in a 20-yr-old
patient with diabetes and necrobiosis lipoidica. Tan et al.
[17] used systemic corticosteroid with success in patients
with necrobiosis lipoidica and insulin-dependent diabe-
tes, and without destabilization of blood glucose levels. In
our patient, long-term topical corticosteroid therapy gave
no detectable clinical improvement.
Narbutt et al. [10] used local PUVA therapy (0.005% 8-
methoxypsoralen followed by UVA irradiation) in 10
patients. After an average of 47 sessions (total dose 69.5 J/
cm2) they observed recurrence of skin lesions in only 2
The patient (female, 45 yr) with primary skin lesions consist- ing of discolored (yellow-brown) areas on both lower legs  with well-separated foci Figure 1
The patient (female, 45 yr) with primary skin lesions 
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patients. Kreuter et al. [18] used fumaric acid esters (FAE)
for the therapy of necrobiosis lipoidica, granuloma annu-
lare and a skin variant of sarcoidosis. In 18 necrobiosis
patients receiving FAE over 6 mo there was a significant
improvement in skin status.
Bouhanick et al. [19] complemented steroid therapy with
113 sessions in hyperbaric chamber. This joint therapy
was effective in a patient (28 yr) with insulin-dependent
diabetes. Reinhard et al. [20] obtained good results in
necrobiosis lipidica treatment using mycophenolate
mofetil. Nguyen et al. [21] described an individual case of
therapeutic success in a patient with necrobiosis after
administration of an antimalarial drug (chloroquine).
Owen et al. [22] reported a case of a 44-yr-old woman
with ulcerated necrobiosis lipoidica that healed following
grafting with dermal tissue engineered in culture. Zeich-
ner et al. [23] treated necrobiosis lipoidica using a TNF
inhibitor (etanercept).
Long-term risks associated with necrobiosis lipoidica
include the development of spinocellular carcinoma.
Tschuchnigg et al. [24] detected nodules within the necro-
biosis foci in a 53-yr-old patient; these were diagnosed
histologically as spinocellular carcinoma. Santos-Juanes
et al. [25] made similar observations in a 75-yr-old patient
with a 30 yr history of necrobiosis lipoidica.
Conclusion
We have described a case with typical clinical and histo-
logical features of necrobiosis lipoidica in the absence of
diabetes, also known as Miescher's granulomatosis. Treat-
ment of this type of necrobiosis is difficult, and the condi-
tion failed to respond to different attempts at therapy over
several years. We report that systemic steroidotherapy
with methylprednisolone was of significant clinical bene-
fit in this patient. Early diagnosis and treatment can not
only improve the patient's quality of life but also protect
against serious side-effects including spinocellular carci-
noma.
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